|
Volumn 112, Issue 7, 2004, Pages
|
Harnessing the HGP for public health
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN E;
APOLIPOPROTEIN E4;
CYCLOSPORIN;
CYTOCHROME P450 2C9;
DNA;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TACROLIMUS;
WARFARIN;
ADVERTIZING;
ALZHEIMER DISEASE;
BLEEDING;
CELL ACTIVITY;
CIGARETTE SMOKING;
DNA REPAIR;
DRUG MONITORING;
DRUG RESEARCH;
DRUG SENSITIVITY;
ENVIRONMENTAL CHANGE;
ENVIRONMENTAL EXPOSURE;
ENVIRONMENTAL FACTOR;
FINANCIAL MANAGEMENT;
GENE FUNCTION;
GENE INTERACTION;
GENETIC ANALYSIS;
GENETIC LINKAGE;
GENETIC POLYMORPHISM;
GENETIC RECOMBINATION;
GENETIC RISK;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
HEALTH CARE ORGANIZATION;
HEART DISEASE;
HEART INFARCTION;
HUMAN;
KIDNEY DISEASE;
KIDNEY FAILURE;
MEDICAL GENETICS;
MEDICAL RESEARCH;
MOTIVATION;
NOTE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
RISK ASSESSMENT;
SINGLE NUCLEOTIDE POLYMORPHISM;
SMOKING CESSATION;
SYMPOSIUM;
THROMBOEMBOLISM;
UNITED KINGDOM;
|
EID: 2642546724
PISSN: 00916765
EISSN: None
Source Type: Journal
DOI: 10.1289/ehp.112-1241998 Document Type: Note |
Times cited : (2)
|
References (0)
|